13 September 2020: Database Analysis
Nomogram for Predicting Breast Cancer-Specific Mortality of Elderly Women with Breast Cancer
Xunxi Lu 12ABCDEF* , Xiaoguang Li 1ADEFG* , Hong Ling 12DFG , Yue Gong 12ACD , Linwei Guo 12ACE , Min He 12DF , Hefen Sun 12DG , Xin Hu 12EFG*DOI: 10.12659/MSM.925210
Med Sci Monit 2020; 26:e925210
Supplementary Table 1 5-, 8-, 10-Year cumulative incidences of OCSD among patients with breast cancer in the training cohort.
| Characteristics | OCSD | ||||
|---|---|---|---|---|---|
| Events (%) | 5-y (%) | 8-y (%) | 10-y (%) | P-value | |
| Total | 3966 (100.0) | 9.1 | 17.3 | 23.0 | |
| Age | |||||
| 65–74 | 1450 (36.6) | 4.8 | 9.7 | 13.4 | |
| 75+ | 2516 (63.4) | 17.0 | 30.8 | 39.9 | |
| Marriage | |||||
| Unmarried | 765 (19.3) | 13.2 | 23.3 | 30.0 | |
| Married | 3201 (80.7) | 8.4 | 16.2 | 21.8 | |
| Race | |||||
| White | 3483 (87.8) | 9.2 | 17.5 | 23.2 | |
| Black | 286 (7.2) | 11.5 | 20.4 | 26.2 | |
| Other* | 197 (5.0) | 5.9 | 11.7 | 17.6 | |
| Histology | 0.621 | ||||
| IDC | 2864 (72.2) | 9.1 | 17.1 | 23.0 | |
| ILC | 327 (8.3) | 9.5 | 17.4 | 21.8 | |
| Other** | 775 (19.5) | 9.0 | 17.7 | 23.5 | |
| Grade | 0.537 | ||||
| I | 1031 (26.0) | 8.3 | 16.7 | 23.0 | |
| II | 1832 (46.2) | 9.2 | 17.5 | 23.3 | |
| III/IV | 1103 (27.8) | 9.8 | 17.3 | 22.3 | |
| Laterality | 0.086 | ||||
| Left | 1969 (49.6) | 9.2 | 16.9 | 22.2 | |
| Right | 1997 (50.4) | 9.1 | 17.7 | 23.8 | |
| ER status | 0.987 | ||||
| Negative | 643 (16.2) | 10.2 | 17.3 | 22.4 | |
| Positive | 3323 (83.8) | 8.9 | 17.3 | 23.1 | |
| PR status | 0.631 | ||||
| Negative | 1158 (29.2) | 10.0 | 17.6 | 22.4 | |
| Positive | 2808 (70.8) | 8.8 | 17.1 | 23.2 | |
| T stage | |||||
| T1 | 2524 (63.6) | 7.7 | 15.6 | 21.7 | |
| T2 | 1187 (30.0) | 11.9 | 20.6 | 25.6 | |
| T3 | 147 (3.7) | 13.3 | 20.5 | 24.8 | |
| T4 | 108 (2.7) | 17.7 | 24.9 | 30.1 | |
| N stage | 0.222 | ||||
| N0 | 2986 (75.3) | 9.0 | 17.4 | 23.6 | |
| N1 | 707 (17.8) | 9.1 | 16.5 | 21.5 | |
| N2 | 183 (4.6) | 11.2 | 18.4 | 21.8 | |
| N3 | 90 (2.3) | 9.9 | 16.0 | 17.4 | |
| Surgery | |||||
| BCS | 2341 (59.0) | 7.8 | 15.4 | 21.3 | |
| Mastectomy | 1625 (41.0) | 11.7 | 20.8 | 26.0 | |
| IDC – infiltrating ductal carcinoma; ILC – infiltrating lobular carcinoma; ER – estrogen receptor; PR – progesterone receptor; BCS – breast-conserving surgery; BCSD – breast cancer-specific death; OCSD – other cause-specific death; T – tumor stage; N – nearby lymph node stage. * Including American Indian/Alaskan native and Pacific Islander; ** including other histology of invasive breast cancer except IDC and ILC. | |||||